You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Notice of retraction

IOS Press has retracted the following publication from its online content: [Cancer Biomarkers, 23(1) (2018), 9–22] DOI: 10.3233/CBM-171002 lncRNA GHET1 down-regulation suppresses the cell activities of gliomaWei Niaa,b,c, Lin Luoa,b,c, Ping Zuoa,b,c, Ren-Ping Lia,b,c, Xiao-Bing Xua,b,c, Fan Wena,b,c and Dong Hua,b,caDepartment of Neurosurgery, The Third Affiliated Hospital of Kunming Medical University, Kunming 650118, Yunnan, ChinabDepartment of Neurosurgery, Yunnan Cancer Hospital, Kunming 650118, Yunnan, ChinacDepartment of Neurosurgery, Yunnan Cancer Center, Kunming 650118, Yunnan, China

The above article originally published in Cancer Biomarkers volume 23, number 1, 2018, pp. 9–22 has been retracted in consultation between the corresponding author and the publisher of Cancer Biomarkers. It was found in further research that there are other more complex mechanisms involed in the LncRNA GHET1 regulation of development of glioma. In order to ensure the scientificity and integrity of the research, the journal has decided to retract it from its online catalogue.